Brief: Pacira BioSciences Notified of Abbreviated New Drug Application Filing from The WhiteOak Group for EXPAREL
21/10/2025 13:35
Oct 21 (Reuters) - Pacira Biosciences Inc PCRX.O: PACIRA BIOSCIENCES NOTIFIED OF ABBREVIATED NEW DRUG APPLICATION FILING FROM THE WHITEOAK GROUP FOR EXPAREL® PACIRA BIOSCIENCES INC - WHITEOAK FILES ANDA FOR GENERIC EXPAREL PACIRA BIOSCIENCES: INTENDS TO ASSERT AND ENFORCE ITS INTELLECTUAL PROPERTY RIGHTS AND HAS 45 DAYS FROM RECEIPT OF PIV NOTICE TO FILE A LAWSUIT Source text: ID:nGNX6XCNkV Further company coverage: PCRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pacira Biosciences
See all newsBrief: Pacira Biosciences Inc - Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote "For" All Of Pacira's Director Nominees
Brief: Pacira Biosciences Urges Stockholders To Vote "For" Election Of Pacira's Nominees On Blue Proxy Card
Brief: Doma Perpetual Urges Pacira Biosciences Shareholders To Judge Sale Price Adequacy
Brief: Doma Perpetual Capital Management Calls For Removal Of Pacira CEO And Strategic Sale
Brief: Pacira Biosciences Sends Letter To Stockholders Reiterating Superior Qualifications Of Its Board Nominees